Korean Journal of Pharmacognosy (생약학회지)

The Korean Society of Pharmacognosy (한국생약학회)
권호 표지

Simultaneous Determination of Asperosaponins and Iridoid Glycosides from Dipsaci Radix by Using LC-ESI-MS Spectrometry

속단(Dipsaci Radix) 중 Asperosaponins 및 Iridoid glycosides의 LC-ESI-MS에 의한 동시분석

  • Received : 2012.02.04
  • Accepted : 2012.04.18
  • Published : 2012.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Dipsaci Radix (Dipsacaceae) has been used as a tonic, an analgesic, anti-inflammatory and anti-complement agents in traditional herbal medicine for the therapy of low back pain, knee pain, rheumatic arthritis, traumatic hematoma, and bone fractures. A high-performance liquid chromatography-electrospray ionization-mass spectrometric method (HPLC-ESI-MS) was developed for the simultaneous quantitation method of the five compounds from the herbal drug: asperosaponin VI and asperosaponin XII (terpene glycosides), sweroside, loganin and dipsacus A(iridoid glycosides). HPLC separation of the analytes was achieved on a C18 column ($150{\times}2.0$ mm i.d., 5 ${\mu}m$) using the aqueous methanol containing 5 mM ammonium acetate with gradient flow of the mobile phase. Detection of the analytes was performed by positive ion electrospray ionization, and selected ion monitoring was used for data acquisition using m/z corresponding molecular adduct ion, $[M+NH_4]^+$ and $[M+H]^+$. Calibration graphs showed good linearity ($r^2$=0.9997) over the wide range of the analytes; intra- and inter-day precisions (RSD, %) were within 9.1% and the accuracy between 94.0-111.0%. Recoveries of the analytes through the assay procedure were in the range of 93.7-110.8%. Analytical results of the herbal drugs of Dipsaci Radix (17 samples) show wide distribution of the five marker compounds and clear difference of the species from Phlomidis Radix (4 samples). The developed method would provide a practical guide for the quality control of the herbal drug.

Keywords

References

  1. Namba, T. (1980) The encyclopedia of Waken-Yaku (Traditional Sino-Japanese Medicines) with Color Pictures, 185-186, Hoiku Publishing Co., LTD., Osaka.
  2. Wang, B. X. (1999) Contemporary pharmacology of Chinese herbal medicine, 1263-1264, Tianjin Science and Technology Press, Tianjin.
  3. Zhou, F. W., Shi, M. S. and Zhou, J. L. (1981) Chinese herbology, 596-597, Shandong Science and Technology Press, Weifang, Shandong.
  4. KFDA (2007) The Korean herbal pharmacopoeia, 222, KFDA, Seoul.
  5. The state commission of Chinese pharmacopeia (2005) Pharmacopoeia of people's republic of China, Part I., 231, Chemical Industry Press, Beijing.
  6. Zhang, Z. J., Qian, Y. H., Hu, H. T., Yang, J. and Yang, G. D. (2003) The herbal medicine Dipsacus asper Wall extract reduces the cognitive deficits and overexpression of betaamyloid protein induced by aluminum exposure. Life Sci. 73: 2443-2454. https://doi.org/10.1016/S0024-3205(03)00649-0
  7. Mazzio, E. A. and Soliman, K. F. (2009) In vitro screening for the tumoricidal properties of international medicinal herbs. Phytother. Res. 23: 385-398. https://doi.org/10.1002/ptr.2636
  8. McGuffin, M. (1997) American herbal products associations botanical safety handbook, CRC Press, Boca Raton, Florida.
  9. Zhao, Y. M. and Shi, Y. P. (2011) phytochemicals and biological activities of Dipsacus species. Chem. Biodivers. 8: 414-430. https://doi.org/10.1002/cbdv.201000022
  10. Jung, K. Y., Son, K. H. and Do, J. C. (1993) Triterpenoids from the roots of Dipsacus asper. Arch. Pharm. Res. 16: 32-35. https://doi.org/10.1007/BF02974125
  11. Niu, Y., Li, Y., Huang, H., Kong, X., Zhang, R., Liu, L., Sun, Y., Wang, T. and Mei, Q. (2011) Asperosaponin VI, a saponin component from Dipsacus asper Wall, induces osteoblast differentiation through bone morphogenetic protein2/p38 and extracellular signalregulated kinase 1/2 pathway. Phytother. Res. 25: 1700-1706. https://doi.org/10.1002/ptr.3414
  12. Zhou, Y. Q., Yang, Z. L., Xu, L., Li, P. and Hu, Y. Z. (2009) Akebia saponin D, a saponin component from Dipsacus asper Wall, protects PC 12 cells against amyloid-beta induced cytotoxicity. Cell Biol. Int. 33: 1102-1110. https://doi.org/10.1016/j.cellbi.2009.06.028
  13. Li, C., Liu, Z., Tian, J., Li, G., Jiang, W., Zhang, G., Chen, F., Lin, P. and Ye, Z. (2010) Protective roles of asperosaponin VI, a triterpene saponin isolated from Dipsacus asper Wall on acute myocardial infarction in rats. Eur. J. Pharmacol. 627: 235-241. https://doi.org/10.1016/j.ejphar.2009.11.004
  14. Zhang, Y. W. and Xue, Z. (1993) Structure determination of saponin XI, XII and XIII from Dipsacus asper Wall. Acta pharmaceutica Sinica 28: 358-363.
  15. Zhang, Y. W. and Xue, Z. (1992) Structure determination of saponin IX and X from Dipsacus asper Wall. Acta pharmaceutica Sinica 27: 912-917.
  16. Wei, F., Lou, Z. C., Liu, Y. M. and Miao, Z. C. (1994) Application of new techniques of NMR in the structure elucidation of two new saponins, asperosaponin F and H1, and spectral rules involved. Acta Pharmaceutica Sinica 29: 511-518.
  17. Tomita, H. and Mouri, Y. (1996) An iridoid glucoside from Dipsacus asperoides. Phytochemistry 42: 239-240. https://doi.org/10.1016/0031-9422(95)00904-3
  18. Tian, X. Y., Wang, Y. H., Liu, H. Y., Yu, S. S. and Fang, W. S. (2007) On the Chemical constiruents of Dipsacus asper. Chem. Pharm. Bull. 55: 1677-1681. https://doi.org/10.1248/cpb.55.1677
  19. Tian, X. Y., Wang, Y. H., Liu, H. Y., Yu, S. S. and Fang, W. S. (2006) Two novel tetrairidoid glucosides from Dipsacus asper. Org. Lett. 8: 2179-2182. https://doi.org/10.1021/ol060676k
  20. Son, J., Lee, J., Han, C. K., Kwak, W. J., Yang, R. and Kim, D. H. (2005) Simultaneous quantitation of loganin and sweroside in plasma using column-switching high-performance liquid chromatography. Anal. Chim. Acta., 503: 257-261.
  21. Chiba, K., Yamazaki, M., Kikuchi, M., Kakuda, R. and Kikuchi, M., (2011) New physiological function of secoiridoids: neuritogenic activity in PC12h cells. J. Nat. Med. 65: 186-190. https://doi.org/10.1007/s11418-010-0449-y
  22. Luo, Y. D., Chen, J., Cao, J., Wen, X. D. and Li, P. (2009) Determination of sweroside in rat plasma and bile for oral bioavailability and hepatobiliary excretion. Chem. Pharm. Bull. 57: 79-83. https://doi.org/10.1248/cpb.57.79
  23. Park, J. H., Bae, J. Y. and Ahn, M. J. (2009) Pharmacognostical studies on the 'SokDan' from Korea. Kor. J. Pharmacogn. 40: 286-288.
  24. Lee, M. Y., Ryuk, J. A., Kim, H. J., Kim, Y. H., Chae, B. C. and Ko, B. S. (2007) Discrimination of Phlomidis Radix and Dispsaci Radix using random amplified polymorphic DNA analysis. Korea Journal of Oriental Medicine 13: 147-152.
  25. Zhu, H., Ding, L., Shakya, S., Qi, X., Hu, L., Yang, X. and Yang, Z. (2011) Simultaneous determination of asperosaponin VI and its active metabolite hederagenin in rat plasma by liquid chromatography-tandem mass spectrometry with positive/negative ion-switching electrospray ionization and its application in pharmacokinetic study. J. Chromatogr. B. 879: 3407-3414. https://doi.org/10.1016/j.jchromb.2011.09.014
  26. Shakya, S., Zhu, H., Ding, L., Du, X. L., Qi, X. M., Yang, X. L. and Yang, Z. L. (2012) Determination of asperosaponin VI in dog plasma by high-performance liquid chromatographytandem mass spectrometry and its application to a pilot pharmacokinetic study. Biomed. Chromatogr. 26: 109-114. https://doi.org/10.1002/bmc.1634
  27. Li, K., Ding, L., Yang, Z. L., Liu, E. H., Qi, L. W., Li, P. and Hu, Y. Z. (2010) Determination of asperosaponin VI in rat plasma by HPLC-ESI-MS and its application to preliminary pharmacokinetic studies. Biomed. Chromatogr. 24: 550-555.
  28. Li, K., Yang, X. L., Zhang, C. F. and Yang, Z. L. (2009) Metabolites of asperosaponin VI in rats' feces by HPLC-MS. Chin. J. Nat. Med. 7: 440-443.
  29. Guan, X. Y., Li, H. F., Yang, W. Z., Lin, C. H., Sun, C., Wang, B. R., Guo, D. A. and Ye, M. (2011) HPLC-DAD-$MS^n$ analysis and HPLC quantitation of chemical constituents in Xianling-gu-bao capsules. J. Pharm. Biomed. Anal. 55: 923-933. https://doi.org/10.1016/j.jpba.2011.03.021